149 related articles for article (PubMed ID: 9358486)
21. Effect of electrode configuration and capacitor size on internal atrial defibrillation threshold using leads currently used for ventricular defibrillation.
Neri R; Palermo P; Cesario AS; Baragli D; Amici E; Laudadio MT; De Rosa A; DeSeta F; Mongeon L; Gambelli G
J Interv Card Electrophysiol; 1999 Jul; 3(2):149-53. PubMed ID: 10387142
[TBL] [Abstract][Full Text] [Related]
22. Can early timed internal atrial defibrillation shocks reduce the atrial defibrillation threshold?
Fotuhi PC; Cooper RA; Sreenan CM; Rollins DL; Smith WM; Ideker RE
Pacing Clin Electrophysiol; 1999 Aug; 22(8):1179-85. PubMed ID: 10461294
[TBL] [Abstract][Full Text] [Related]
23. Capture of atrial fibrillation reduces the atrial defibrillation threshold.
Villani GQ; Nollo G; Ravelli F; Piepoli M; Capucci A
Pacing Clin Electrophysiol; 2002 Aug; 25(8):1159-65. PubMed ID: 12358164
[TBL] [Abstract][Full Text] [Related]
24. Clinical study of the acute effects of intravenous nifekalant on the defibrillation threshold in patients with persistent and paroxysmal atrial fibrillation.
Okishige K; Uehara H; Miyagi N; Nakamura K; Azegami K; Wakimoto H; Ohba K; Hirao K; Shimabukuro M; Isobe M
Circ J; 2008 Jan; 72(1):76-80. PubMed ID: 18159104
[TBL] [Abstract][Full Text] [Related]
25. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.
Boriani G; Biffi M; Capucci A; Bronzetti G; Ayers GM; Zannoli R; Branzi A; Magnani B
J Am Coll Cardiol; 1999 Feb; 33(2):333-41. PubMed ID: 9973012
[TBL] [Abstract][Full Text] [Related]
26. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
[TBL] [Abstract][Full Text] [Related]
27. Bifocal versus unifocal right atrial pacing under plasma level controlled sotalol to prevent atrial fibrillation in patients with symptomatic sinus bradycardia and paroxysmal atrial fibrillation.
Stockburger M; Gerhardt L; Helms S; Schlegl M; Butter C
Herzschrittmacherther Elektrophysiol; 2007 Dec; 18(4):250-8. PubMed ID: 18084799
[TBL] [Abstract][Full Text] [Related]
28. Multistage electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation with lower energy than a single biphasic shock.
Janardhan AH; Gutbrod SR; Li W; Lang D; Schuessler RB; Efimov IR
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):40-8. PubMed ID: 24076284
[TBL] [Abstract][Full Text] [Related]
29. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.
Tse HF; Lau CP; Ayers GM
Heart; 1999 Sep; 82(3):319-24. PubMed ID: 10455082
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
[TBL] [Abstract][Full Text] [Related]
31. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
32. High Atrial Defibrillation Threshold With Internal Cardioversion Indicates Arrhythmogenicity of Superior Vena Cava in Non-Long-Standing Persistent Atrial Fibrillation.
Ihara K; Sasaki T; Shirai Y; Tao S; Maeda S; Kawabata M; Sasano T; Yokoyama Y; Isobe M; Hirao K
Circ J; 2015; 79(7):1479-85. PubMed ID: 25818636
[TBL] [Abstract][Full Text] [Related]
33. Defibrillation efficacy and pain perception of two biphasic waveforms for internal cardioversion of atrial fibrillation.
Jung J; Hahn SJ; Heisel A; Buob A; Schubert BD; Siaplaouras S
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):837-40. PubMed ID: 12890046
[TBL] [Abstract][Full Text] [Related]
34. Reduction in atrial defibrillation threshold by a single linear ablation lesion.
White JB; Fotuhi PC; Pedoto RW; Chattipakorn N; Rogers JM; Ideker RE
J Cardiovasc Electrophysiol; 2001 Apr; 12(4):463-71. PubMed ID: 11332570
[TBL] [Abstract][Full Text] [Related]
35. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F
Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670
[TBL] [Abstract][Full Text] [Related]
36. Transvenous single lead atrial defibrillation: efficacy and risk of ventricular fibrillation in an ischemic canine model.
Osswald S; Trouton TG; Roelke M; O'Nunain SS; Fallon JT; Holden HB; Ruskin JN; Garan H
Pacing Clin Electrophysiol; 1998 Mar; 21(3):580-9. PubMed ID: 9558691
[TBL] [Abstract][Full Text] [Related]
37. Effects of left atrial dilatation on the endocardial atrial defibrillation threshold: a study in an ovine model of pacing induced dilated cardiomyopathy.
Power JM; Beacom GA; Alferness CA; Raman J; Farish SJ; Tonkin AM
Pacing Clin Electrophysiol; 1998 Aug; 21(8):1595-600. PubMed ID: 9725159
[TBL] [Abstract][Full Text] [Related]
38. Effects of atrial fibrillation substrate and spatiotemporal organization on atrial defibrillation thresholds.
Everett TH; Wilson EE; Olgin JE
Heart Rhythm; 2007 Aug; 4(8):1048-56. PubMed ID: 17675080
[TBL] [Abstract][Full Text] [Related]
39. Effect of increased parasympathetic and sympathetic tone on internal atrial defibrillation thresholds in humans.
Barold HS; Shander G; Tomassoni G; Simons GR; Wharton JM
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):238-42. PubMed ID: 9990638
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of transvenous atrial cardioversion in patients with mitral valve disease and long-standing atrial fibrillation.
Grönefeld GC; Li YG; Bogun F; Hohnloser SH
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1894-7. PubMed ID: 11139952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
